Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 20, 2025 08:15 ET | Source: Napigen, Inc.

USDA Informs NAPIGEN, Inc. Its CMS Rice Is Not Subject to Regulation

The U.S. Department of Agriculture told NAPIGEN, Inc. the company's rice with gene-edited mitochondrial DNA is not subject to regulation.
March 11, 2024 08:15 ET | Source: Napigen, Inc.

NAPIGEN, Inc. Secures U.S. Patent, Awarded USDA SBIR Grant

The USPTO issued a patent to NAPIGEN for the use of CRISPR technologies to edit organellar genomes. Separately, USDA awarded NAPIGEN an SBIR phase 1 grant.
July 12, 2022 08:15 ET | Source: Napigen, Inc.

NAPIGEN Completes $7.85 Million Funding Round to Advance Its Mitochondrial and Chloroplast Gene Editing Technology

WILMINGTON, Del., July 12, 2022 (GLOBE NEWSWIRE) -- NAPIGEN, a company developing proprietary technology to edit mitochondrial and chloroplast genomes, completed a $7.85 million seed funding round. ...
January 28, 2020 08:15 ET | Source: Napigen, Inc.

NAPIGEN Publication Provides Proof of Concept of its Technology for Editing Cytoplasmic Genome (Mitochondrial and Chloroplast Genome)

WILMINGTON, Del., Jan. 28, 2020 (GLOBE NEWSWIRE) -- NAPIGEN, a company developing proprietary technology to edit mitochondrial and chloroplast genomes, said it demonstrated for the first time the...